A company still losing money with growing sales, with elevated risk. Institutions are trimming.
Facts from SEC filings, not a recommendation.
Last 12 months: $25.7M, up 116% from the 12 months before. Over 5 years, sales shrank about 15% a year.
Price chart by TradingView.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, share count not growing, gross margin 40%+. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions cut 56.9% from their holdings. 4 bought, 6 sold. 2 quarters of net selling in a row.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page